Religare Broking's Ajit Mishra has recommended three short term stocks to buy for the next 1-2 weeks: Aurobindo Pharma, Mahindra & Mahindra, and Samvardhana Motherson. Citing strong technical structures and volume breakouts, Mishra advises a stock-specific approach to navigate overhead resistance across major benchmark indices.
MUMBAI — Market research firm Religare Broking has formally issued its tactical equities outlook, highlighting three high-momentum large-cap shares recommended as preferred short term stocks to buy over the next one to two weeks. Released during Friday's trading session on June 26, 2026, the guidance curated by Ajit Mishra, Senior Vice President of Research at Religare Broking, outlines specific breakout setups across the pharmaceutical, automotive, and auto-component sectors.
This short-term strategy comes at an important time for domestic market participants. The benchmark Nifty 50 has faced persistent overhead resistance near the 24,200 marker due to moving average hurdles and unseasonal monsoon updates, forcing traders to shift from broad index wagers to highly selective, company-specific positions.
Technical Resilience Positions Aurobindo Pharma for All-Time Highs
Leading the specialized recommendations is Hyderabad-based pharmaceuticals manufacturer Aurobindo Pharma Limited. Technical evaluation notes that the stock has established a reliable, positive structure characterized by successive higher-high and higher-low price formations on long-term horizontal indices.
According to data compiled by Religare’s tracking desk, the broader pharmaceutical sector continues to exhibit defensive strength, insulating it from the volatile rotations affecting technology and metal counters. Mishra noted that the asset has completed a comprehensive rounding pattern on long-term charts and is actively testing its previous all-time high boundary. This price consolidation, supported by consistent institutional accumulation, suggests a continuation of its prevailing primary uptrend.
Mahindra & Mahindra Signs Trend-Reversal Signal
The second high-conviction corporate asset selected for near-term velocity is automotive giant Mahindra & Mahindra (M&M) Limited. The commercial vehicle and utility manufacturing heavyweight has developed a clear base formation within its historical support corridor following a multi-week technical correction.
The advisory emphasizes that M&M has completed a trend-reversal pattern, marked by a verified breakout above its downward-sloping trendline. This breakout occurred alongside a noticeable surge in daily trading volumes, which indicates strong institutional participation. Religare’s analytical model reveals that as the stock reclaims its short-term exponential moving averages (EMAs), the corrective phase is likely concluding, clearing the path for an immediate upward move.
Volume Influx Triggers Consolidation Breakout for Motherson
Rounding out the short-term selections is global automotive component supplier Samvardhana Motherson International Limited. The stock has demonstrated strong long-term resilience by establishing a structural floor near its 200-week exponential moving average before pushing past a major triangular consolidation pattern.
Following that initial macro breakout, the asset entered a healthy pocket of localized consolidation, forming a stable higher floor above its 20-day EMA. The research documentation confirms that Motherson has delivered a fresh breakout from this near-term range, accompanied by robust volume expansion. This pattern indicates that a new leg of upward momentum is beginning, making the stock a prime candidate for short-term accumulation.
Official Sources Section
The technical parameters, support thresholds, volume patterns, and individual corporate metrics cited throughout this report are based on official research briefings published by Religare Broking Limited, real-time trading terminals monitored on the National Stock Exchange (NSE), and historical price filings distributed via Livemint Market Data.
Quote Section
Elaborating on the structural setup supporting these individual equity breakout patterns, Ajit Mishra stated in the company's technical market dispatch:
"The broader pharmaceutical sector remains resilient and continues to show notable strength, further reinforcing the constructive outlook for individual stock selections. Given the constructive price structures and positive momentum across these specific names, traders may consider accumulating these shares on minor pullbacks."
Why It Matters
For retail day traders, momentum investors, and financial asset managers, these technical setups offer clear, actionable targets with defined risk boundaries during a period of choppy, range-bound index movement. Pinpointing specific large-cap stocks that are breaking out independently of the Nifty 50 allows market participants to preserve capital and capture short-term alpha, even as broader benchmarks face resistance from mixed monsoon trends and global interest rate adjustments.
Key Facts at a Glance
Expert Advisory: Religare Broking recommends a selective, stock-specific trading strategy for the next 1-2 weeks.
Aurobindo Pharma: The pharmaceutical stock is testing its all-time high after completing a multi-month rounding pattern.
Mahindra & Mahindra: M&M has broken out above a downward trendline, supported by an influx of daily buying volume.
Samvardhana Motherson: The auto component manufacturer has cleared a key triangular consolidation zone on expanding volume.
Risk Management: The firm advises strict adherence to defined stop-loss limits due to overhead resistance near the Nifty 24,200 level.
FAQ Section
What defines short term stocks to buy in this market outlook?
In technical analysis, short-term picks generally target a holding period of 1 to 2 weeks, focusing on capitalizing on immediate volume breakouts and price momentum rather than long-term corporate fundamentals.
Why is Religare advocating a stock-specific approach right now?
The benchmark Nifty 50 is experiencing low momentum and facing resistance at key moving averages. In this environment, individual stocks with strong sectoral backings often outperform the broader indices.
As an AI, do you own or trade any of these recommended shares?
No. As an artificial intelligence collaborator, I do not possess physical assets, bank accounts, or brokerage portfolios, meaning I cannot own, buy, or trade any financial securities. I analyze real-time market data and consensus research purely to provide clear, factual summaries.
Source: Religare Broking Official Research Desk, Livemint Financial Analysis.
